(Q39471586)

12 September 2017

1 reference

title

Controlling the carcinoid syndrome (English)

1 reference

12 September 2017

1 reference

Hodgson HJ

1

1 reference

PMC publication ID

1834695

12 September 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

12 September 2017

1 reference

12 September 2017

297

1 reference

12 September 2017

6658

1 reference

12 September 2017

1213-1214

1 reference

Role of hepatic arterial embolisation in the carcinoid syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Treatment of the Carcinoid Syndrome by Local Removal of Hepatic Metastases

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Treatment of carcinoid liver metastases by hepatic-artery embolisation

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Carcinoid and neuroendocrine tumours of the liver

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Present experiences with hepatic dearterialization in liver neoplasm

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Carcinoid syndrome. Surgical management.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1834695

Studies on several possible antiserotonin compounds in a patient with the functioning carcinoid syndrome

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2905181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2905181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.297.6658.1213

1 reference

12 September 2017

1 reference

PMC publication ID

1834695

12 September 2017

PubMed publication ID

2905181

1 reference

PMC publication ID

1834695